Bristol-Myers Squibb CompanyBMYNYSE
Loading
Net Income ScalingExpanding
Percentile Rank93
3Y CAGR+3.7%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
+3.7%/yr
vs +6.5%/yr prior
Acceleration
-2.8pp
Decelerating
Percentile
P93
Near historical high
vs 3Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $7.05B | +178.8% |
| 2024 | $-8.95B | -211.5% |
| 2023 | $8.03B | +26.8% |
| 2022 | $6.33B | -9.5% |
| 2021 | $6.99B | +177.8% |
| 2020 | $-8.99B | -361.6% |
| 2019 | $3.44B | -30.1% |
| 2018 | $4.92B | +388.6% |
| 2017 | $1.01B | -77.4% |
| 2016 | $4.46B | - |